-- Thursday, 11 June 2020
New investors for INBRAIN to develop graphene-based implants against brain disorders
INBRAIN Neuroelectronics, a spin-off of the Catalan Institute of Nanoscience and Nanotechnology and ICREA, receives funding from Sabadell Asabys and Alta Life Sciences, as well as ICF and Finaves, which will allow the company to speed up the development of novel graphene-based implants to optimise the treatment of brain disorders, such as Parkinson's and epilepsy.
